Ekso Bionics
Wearable exoskeletons for rehabilitation, personal mobility, and industrial arm support.
Something off on this page? Send us feedback.
Profile
Ekso Bionics provides wearable exoskeletons for neurorehabilitation, personal mobility after spinal cord injury, and industrial arm support. It is pursuing a business combination with Applied Digital Cloud that would rename the company ChronoScale if completed.
Ekso Bionics Holdings is a San Rafael, California company founded in 2005 that designs, develops and markets exoskeleton and complementary rehabilitation products. Its healthcare portfolio includes EksoNR for clinician-led gait training in spinal cord injury, acquired brain injury including stroke and traumatic brain injury, and multiple sclerosis; Ekso Indego Therapy for rehabilitation and wellness applications; and Ekso Indego Personal for home and community ambulation by eligible spinal cord injury users.
It also provides EksoCare service, support and training, distributes products through direct and partner channels, and offers EVO for upper-body industrial ergonomics. Recent filings say most sales still come from Enterprise Health clinical customers, while Personal Health depends on reimbursement partners and documentation. Ekso has agreed to combine with Applied Digital Cloud; closing depends on required approvals, financing, Nasdaq listing review and other conditions, after which the company expects to rename itself ChronoScale.
Company facts
Key statistics
Year to date +103% · Average volume (30d) 386.3K
Analysts
No analyst consensus on record.
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Apr 28, 2026Q1 FY26 | −$0.03 | −$2.04 | −6,700.0% | $4.3M | $2.1M | −50.1% | +2.05% |
| Feb 23, 2026Q4 FY25 | −$0.08 | −$1.56 | −1,850.0% | $5.0M | $3.1M | −37.5% | −4.42% |
| Oct 28, 2025Q3 FY25 | −$0.99 | −$0.54 | +45.5% | $5.0M | $4.2M | −15.9% | +9.15% |
| Jul 28, 2025Q2 FY25 | −$1.20 | −$1.24 | −3.3% | $4.1M | $2.1M | −50.4% | −27.37% |
Financial highlights
| 12 quarters | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $5.1M | $3.4M | $2.1M | $4.2M | $3.1M | $2.1M | |
| Gross profit | $2.7M | $1.8M | $819.0K | $2.5M | $1.7M | $1.1M | |
| Operating income | −$2.2M | −$3.4M | −$4.0M | −$1.4M | −$4.5M | −$5.6M | |
| Net income | −$3.4M | −$2.9M | −$2.7M | −$1.4M | −$4.7M | −$6.9M | |
| Diluted EPS | −$2.08 | −$1.71 | −$1.24 | −$0.54 | −$1.57 | −$2.04 | |
| Gross margin | 53.3% | 53.5% | 39.8% | 60.3% | 53.2% | 50.2% | |
| Operating margin | -43.8% | -101.9% | -193.2% | -33.2% | -143.6% | -262.4% |
Fiscal years (4-quarter sums)FY21 $11.2M · FY22 $12.9M · FY23 $18.3M · FY24 $17.9M · FY25 $12.8M
Revenue by geography · Q1 FY26
Balance sheet, Mar 31, 2026Cash & short-term investments $4.0M · Total debt $4.3M · Total assets $19.7M · Shareholders' equity $5.7M
Dividends
No dividends on record.
Ownership
Shares outstanding 2.43M · Float 1.81M
This issuer lists more than one class and the share count spans them all, so a stake here reads as a share of the whole company, not of this class.
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % of company | Form | Filed |
|---|---|---|---|---|
| Asher Daniel · 10 percent owner | 435.4K | 17.95% | Form 4 | Feb 20, 2026 |
| Dba Trading, LLC | 270.4K | 11.15% | 13F | May 8, 2026 |
| Hood River Capital Management LLC | 133.6K | 5.51% | 13F | May 15, 2026 |
| Mink Brook Asset Management LLC | 95.3K | 3.93% | 13F | Apr 1, 2026 |
| Shay Capital LLC | 80.3K | 3.31% | 13F | May 15, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Mar 16, 2026 | Jerome Wong | officer: Chief Financial Officer | +1,308 | $11.85 |
| Mar 16, 2026 | Jason C. Jones | officer: Chief Operating Officer | +1,308 | $11.85 |
| Feb 19, 2026 | Daniel Asher | 10 percent owner | +16,740 | $12.11 |
| Feb 6, 2026 | Daniel Asher | 10 percent owner | +194 | $9.86 |
| Feb 9, 2026 | Daniel Asher | 10 percent owner | +4,800 | $9.96 |
Peers
Not reported.